近十年来,研究肝细胞癌(HCC)的一项重要进展是提出了一种独特的亚型即肝纤维板层癌(Fibrolamellar Carcinoma of the liver,FLC)。以往认为,HCC的预后很差,其组织学类型与其生物学行为无关。近年来发现FLC无论其病理特征还是临床表现(尤其是预后方面)都与普通型HCC有明显不同,特别是研究FLC的 In the past decade, an important development in the study of hepatocellular carcinoma (HCC) has been the development of a unique subtype, Fibrolamellar Carcinoma of the liver (FLC). In the past, the prognosis of HCC was poor, and its histological type had nothing to do with its biological behavior. In recent years, it has been found that FLC, regardless of its pathological characteristics or clinical manifestations (especially the prognosis), is significantly different from that of ordinary HCC, especially the study of FLC.